Some tests identify genetic risk factors for specific health conditions. Consult a healthcare professional for comprehensive health risk understanding.
It Can test all types of genetic testing . Below
ColoComprehensive |IHC, ER-PR & Her2 by IHC |HER2 By FISH |HER2 By Digital PCR |BRCA1&2 by NGS - BRCA1&2 |Somatic BRCA 1&2 |
OncoCEPT - Solid |EGFR by NGS |EGFR T790M |OncoCEPT-Liquid |HPV 16/18 |HPV-high risk strains |OncoCEPT Solid Comprehensive | KRAS+NRAS+BRAF Oncocept Solid - Onco.colon |GIST Panel Oncocept Solid - Onco.GIST | Thyroid Cancer Panel OncoCEPT Solid - Onco.Thyroid |
Oncocept Solid Breast Cancer Panel (ER+Her2-) - Onco.Breast |HRR Gene Panel |Oncocept Solid Single Gene - Onco.single
Microsatellite Instability - Onco.MSI |MMR IHC PANEL for MSI |IHC Marker PDL1 |ORION whole Exome/ Comprehensive Cancer/ Inherited Cancer Germline | Karyotyping from Blood |Karyotyping from Amniotic Fluid |Chromosome 21 for trisomy (Down's Syndorme) | Sex Chromosome-X/Y |Pre/ Postnatal FISH Panel- 13, 18, & 21 | FISH for Pre/ Postnatal Chromosome 13, 18, 21, X and Y | Y-chromosomal microdeletion |
"CytoScan Optima/POC Microarray/Cytoscan 315K/Microarray Rapidsure/Constitutional/ Di George by Microarray/ Prader Willi-Angelmann by Microarray | Prenatal Microarray/ Cytoscan 315K* (MCC is recommended) | Cytoscan 750K/Microarray Rapidsure Deepdive | Non Invasive Prenatal Testing- Focus | Non Invasive Prenatal Testing- Comprehensive | Non Invasive Prenatal Testing- Plus | Beta Thal Trio
Prenatal Sanger Validation | ORION-TRIO-PROBAND | Prenatal ORION | Lumous Plus (Female)/LUMPLUSFEM | Lumous Plus (Male)/LUMPLUSMAL
Lumous Comprehensive (Female)/LUMCOMPFEM | Lumous Comprehensive (Male)/LUMCOMPMAL | Lumous Focus (Female)/LUMFOCSFEM | Lumous Focus (Male)/LUMFOCSMAL | PGS FOR 1 EMBRYO (Extended)/PGT-A | PGT-SR | Pre PGD Work-Up | PGD 1 Embryo/PGT-M | Sperm DNA Fragmentation Study
TORCH PCR | Endometrial Receptivity Assay (ERA) | HLA - A,B,C,DR,DQ High resolution by NGS | HLA Test Package For Cadaver Recipient (HLA Typing, PRA & Single antigen) | HLA - A,B,C,DR,DQ low resolution by Luminex | HLA - A,B,DR low resolution by Luminex
HLA - A |HLA - B |HLA B 1502 |HLA - C |HLA - DR | HLA - DQ High Resolution | HLA DQA1 |HLA (DRB1 and DQA1)
HLA DRB 3,4,5 |HLA -G |DSA By Luminex (HLA Cross Match |LCM-CDC | Lymphocyte Auto donor cross matching |Lymphocyte Auto Patients cross matching | Lymphocyte DTT treated serum cross matching |Single Antigen Class-I |Single Antigen Class-II
Panel Reactive Antibody HLA- Class-I | Panel Reactive Antibody HLA- Class-II |Antibody screening for HLA Class I & II
MIC-A Single Antibodies Panel | Flow cytometery lymphocyte (T and B cell) cross match
MIC-A Typing | KIR Genotype |BCR-ABL1 (IS) by Real-time PCR | BCR-ABL1 Qualitative Multiplex for Detection of Transcript
JAK2 V617F Mutation Study by Real-time PCR (V617F) | JAK2 Mutation Panel (Exons 12 to 15) | Onco haem (DNA+RNA) (AML and B-ALL By NGS)
Onco haem: DNA only by NGS | Onco haem: RNA only by NGS | Chimerism Study Mutation Analysis | PML-RARA Fusion Gene Detection (Qualitative) |PML-RARA Fusion Gene Detection (Quantitative) | Karyotyping From Bonemarrow | Del(5q) by FISH | Del(7q) By FISH
Del(20q) By FISH | E2A/TCF3 detection by FISH | IgH By FISH | INV 16 by FISH | TEL-AML by FISH | AML1-ETO By FISH | MLL By FISH | 11q (ATM) By FISH | 17p (p53) By FISH | PDGFR Alpha By FISH | PDGFR Beta By FISH | PML-RARA Detection By FISH |BCR-ABL1 By FISH
Trisomy 8 by FISH | ALL Panel By FISH |AML Panel By FISH | CLL Panel By FISH |MDS Panel By FISH | MM Panel By FISH |Stress Cytogenetics
MYEOV/IGH by FISH t(11;14) | BCL2/IGH (Follicular lymphoma) By FISH | BCL-6 By FISH |ORION (Whole Exome Sequencing with CNV calling, WES)
ORION Focus (Clinical exome based disease panels) | ORION (Single gene) | ORION Trio (Whole Exome Sequencing) | Mitochondrial Genome sequencing | Prenatal ORION |BRCA1&2 by NGS - BRCA1&2 | Beta thal common mutations | Beta Globin Gene Sequencing | Beta globin Trio / Beta thal trio | Congenital adrenal hyperplasia testing: CYP21A2 analysis (seq+ MLPA)/ Congenital Adrenal Hyperplasia (Seq+MLPA)
Duchenne Muscular Dystrophy (DMD) by MLPA | Fragile X syndrome | Huntington Disease Molecular Assay | Maternal cell contamination
Spinal Muscular Atrophy (SMA) By MLPA | Sanger validation | Aneuploidy detection by QF-PCR | Prenatal microarray (Cytoscan Optima)
Microarray Constitutional | Microarray Rapidsure Deepdive/Microarray 750K | Lumous Plus (Female)/LUMPLUSFEM |Lumous Plus (Male)/LUMPLUSMAL
Lumous Comprehensive (Female)/LUMCOMPFEM | Lumous Comprehensive (Male)/LUMCOMPMAL |Lumous Focus (Female)/LUMFOCSFEM |Lumous Focus (Male)/LUMFOCSMAL
